Tedisamil inactivates transient outward K+ current in rat ventricular myocytes
- PMID: 2556052
- DOI: 10.1152/ajpheart.1989.257.5.H1746
Tedisamil inactivates transient outward K+ current in rat ventricular myocytes
Abstract
The action of tedisamil, a new bradycardiac agent with antiarrhythmic properties, was investigated in single rat ventricular myocytes using the whole cell voltage-clamp technique. Under current clamp conditions, 1-20 microM tedisamil caused marked prolongations of the action potential. Over the same concentration range, in voltage-clamped myocytes, tedisamil suppressed the transient outward current (ito) and enhanced its inactivation in a dose-dependent manner. The half-maximal dose for the effect of tedisamil on ito was approximately 6 microM. Tedisamil had no significant effects on the inwardly rectifying potassium current and calcium current but did suppress the sodium current at concentrations greater than 20 microM. Our findings suggest that tedisamil represents a new type of antiarrhythmic agent that primarily suppresses the transient outward K+ current.
Similar articles
-
Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells.J Pharmacol Exp Ther. 1990 Aug;254(2):560-9. J Pharmacol Exp Ther. 1990. PMID: 2384886
-
Mechanism of block by tedisamil of transient outward current in human ventricular subepicardial myocytes.Br J Pharmacol. 1998 Oct;125(4):659-66. doi: 10.1038/sj.bjp.0702110. Br J Pharmacol. 1998. PMID: 9831899 Free PMC article.
-
Different inhibition patterns of tedisamil for fast and slowly inactivating transient outward current in rat ventricular myocytes.Naunyn Schmiedebergs Arch Pharmacol. 1998 Mar;357(3):291-8. doi: 10.1007/pl00005170. Naunyn Schmiedebergs Arch Pharmacol. 1998. PMID: 9550301
-
Tedisamil: master switch of nature?Expert Opin Investig Drugs. 2001 Jan;10(1):129-38. doi: 10.1517/13543784.10.1.129. Expert Opin Investig Drugs. 2001. PMID: 11116286 Review.
-
Tedisamil in coronary disease: additional benefits in the therapy of atrial fibrillation?J Cardiovasc Pharmacol Ther. 2003 Jun;8 Suppl 1:S33-7. doi: 10.1177/107424840300800105. J Cardiovasc Pharmacol Ther. 2003. PMID: 12746750 Review.
Cited by
-
Tedisamil and dofetilide-induced torsades de pointes, rate and potassium dependence.Br J Pharmacol. 2001 Apr;132(7):1493-500. doi: 10.1038/sj.bjp.0703967. Br J Pharmacol. 2001. PMID: 11264243 Free PMC article.
-
Tedisamil blocks single large-conductance Ca(2+)-activated K+ channels in membrane patches from smooth muscle cells of the guinea-pig portal vein.Pflugers Arch. 1991 May;418(4):308-12. doi: 10.1007/BF00550866. Pflugers Arch. 1991. PMID: 1876480
-
Different mechanisms of the inhibition of the transient outward current in rat ventricular myocytes.Naunyn Schmiedebergs Arch Pharmacol. 1994 Jan;349(1):87-94. doi: 10.1007/BF00178211. Naunyn Schmiedebergs Arch Pharmacol. 1994. PMID: 8139705
-
The calcium antagonist D600 inhibits calcium-independent transient outward current in isolated rat ventricular myocytes.J Physiol. 1991 Jan;432:65-80. doi: 10.1113/jphysiol.1991.sp018376. J Physiol. 1991. PMID: 1653326 Free PMC article.
-
RSD1019 suppresses ischaemia-induced monophasic action potential shortening and arrhythmias in anaesthetized rabbits.Br J Pharmacol. 2000 Oct;131(3):405-14. doi: 10.1038/sj.bjp.0703592. Br J Pharmacol. 2000. PMID: 11015289 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical